X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Merck Ltd with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs MYLAN (US) - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 MERCK   MYLAN
EQUITY SHARE DATA
    MERCK
Dec-17
MYLAN
Dec-14
MERCK/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,3584,158-   
Low Rs9332,930-   
Sales per share (Unadj.) Rs665.01,423.5-  
Earnings per share (Unadj.) Rs56.6171.5-  
Cash flow per share (Unadj.) Rs72.5276.0-  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs441.7707.6-  
Shares outstanding (eoy) m16.60378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x1.72.5 69.2%   
Avg P/E ratio x20.220.7 97.9%  
P/CF ratio (eoy) x15.812.8 123.1%  
Price / Book Value ratio x2.65.0 51.8%  
Dividend payout %26.50-   
Avg Mkt Cap Rs m19,0111,341,063 1.4%   
No. of employees `0001.525.0 6.2%   
Total wages/salary Rs m1,6960-   
Avg. sales/employee Rs Th7,150.021,545.0 33.2%   
Avg. wages/employee Rs Th1,098.70-   
Avg. net profit/employee Rs Th608.22,595.4 23.4%   
INCOME DATA
Net Sales Rs m11,040538,624 2.0%  
Other income Rs m240-3,140 -7.6%   
Total revenues Rs m11,279535,485 2.1%   
Gross profit Rs m1,376133,958 1.0%  
Depreciation Rs m26439,560 0.7%   
Interest Rs m023,233 0.0%   
Profit before tax Rs m1,35268,026 2.0%   
Minority Interest Rs m0-279 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5832,861 20.4%   
Profit after tax Rs m93964,886 1.4%  
Gross profit margin %12.524.9 50.1%  
Effective tax rate %43.14.2 1,025.2%   
Net profit margin %8.512.0 70.6%  
BALANCE SHEET DATA
Current assets Rs m7,523473,522 1.6%   
Current liabilities Rs m2,253370,200 0.6%   
Net working cap to sales %47.719.2 248.9%  
Current ratio x3.31.3 261.1%  
Inventory Days Days5278 66.8%  
Debtors Days Days41107 37.8%  
Net fixed assets Rs m1,240124,609 1.0%   
Share capital Rs m16619,047 0.9%   
"Free" reserves Rs m7,1670-   
Net worth Rs m7,333267,749 2.7%   
Long term debt Rs m0399,991 0.0%   
Total assets Rs m9,9121,078,470 0.9%  
Interest coverage xNM3.9-  
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x1.10.5 223.0%   
Return on assets %9.58.2 116.0%  
Return on equity %12.824.2 52.8%  
Return on capital %20.813.6 152.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,0280-   
CASH FLOW
From Operations Rs m53770,803 0.8%  
From Investments Rs m-476-55,837 0.9%  
From Financial Activity Rs m-220-18,656 1.2%  
Net Cashflow Rs m-160-3,691 4.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69.77 Rs / USD

Compare MERCK With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare MERCK With: TTK HEALTHCARE  STRIDES PHARMA SCIENCE  ABBOTT INDIA  STERLING BIOTECH  AJANTA PHARMA  



Today's Market

Sensex Ends 382 Points Lower; Auto and Telecom Stocks Witness Selling(Closing)

India share markets witnessed huge selling pressure during closing hours and ended their trading session deep in the red.

Related Views On News

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


May 21, 2019 (Close)

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS